| abstract |
The present invention relates to a phosphatidylinositol 3-kinase inhibitor compound 4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine or a pharmaceutically acceptable salt thereof, Sodium stearyl fumarate, and optionally one or more additional pharmaceutically acceptable carriers. The invention also relates to a method for its preparation and to its use as a medicament for cancer treatment. |